Daff singing contest on Saturday

[email protected] (CD Network)
April 20, 2012

DUFF

Mangalore, April 19: An inter-State floodlight Daff singing and playing competition will be held on the premises of Government High School at Kukkaje in Bantwal Taluk on April 21 at 9 p.m.

Announcing this at a press meet Abdul Latheef Neralakatte, President, Daff Association of Dakshina Kannada and Udupi, said, as many as, 13 Daff trainers from Dakshina Kannada and Udupi would be felicitated prior to the commencement of the competition at 7 p.m.

The former Minister B. Janardhana Poojary, MLAs U.T. Khader, B. Ramanatha Rai, and Abhayachandra Jain, and MP Jayaprakash Hegde will be the guests.

As many as 28 troupes have registered for the competition. Each troupe would be given Rs. 1,000 as honorarium.

The best performing troupes would be given mementoes and 15 members from each troupe would get individual prizes.

In addition, there prizes for best and second best singers would be given. Each troupe would be allowed to sing up to 11 minutes. A “souhardotsava” will also be held.

The competition is being organised under the joint association of the Daff Association of Dakshina Kannada and Udupi and Friends Association of Kukkaje.

Abdul Razzak Kukkaje, President, Friends Association of Kukkaje and P M Ashraf, General Secretary, Daff Association, were also present in press meet.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 14,2020

Udupi, Mar 14: Amidst growing Coronavirus scare, a youth with suspected Coronavirus symptoms was admitted to Udupi District Hospital here, District Health and Family Welfare Officer Sudhir Chandrachud said.

According to him, A 37-year-old youth, a native of Shirwa, who works in a Japanese ship and was onboard a Japanese vessel that was recently blocked due to the coronavirus. However, he was left out on its way to Dubai, where he was diagnosed with coronavirus infection and he returned to his native.

However, he did not show any of the primary symptoms of coronavirus, such as cough, cold, fever, but he was suffering from diarrhea and abdominal pain with slight respiratory problems following which he has been admitted to an isolated ward in the district hospital here on Friday evening.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

Bantwal, Jun 16: Two unmarred siblings committed suicide by self-immolation at Sangabettu in Bantwal taluk of Dakshina Kannada last night.

Neelayya Shettogar (42) and his sister Kesari (39) poured petrol on themselves before torching themselves at around 11 p.m. on June 15 inside a room of their house, police sources said. The siblings were reportedly facing health problems.

Neelayya's brother and latter’s wife were sleeping in the other room of the same house when the incident took place. They came to know only when they heard the screams of the duo.

Even though the siblings were rushed to the government hospital at Bantwal with the help of locals, the doctors declared them dead.

Bantwal rural police sub-inspector, Prasanna and staff visited the spot as part of investigation.

Comments

Mohammad Mansoor
 - 
Tuesday, 16 Jun 2020

Very sad. What happening to our youths. Are they going crazy or the mountain fell on them?  Why do our people are becoming so coward? I think many are going under depression. Govt should set up rehabilitation/counselling centres in each Mandals/Taluks/Districts to treat such people.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.